Month: September 2018

FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History

TORONTO, Sept. 12, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 11, 2018 the Company traded an aggregate total of exactly 213,761,823 shares. FSD traded 143,260,988 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 1,888,500 on AQC-Lit,

Continue Reading “FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History”

Deveron UAS Teams With A & L Canada to Improve Farm Productivity

Deveron UAS Corp., a drone data services company based out of Toronto, Ontario, has teamed up with A & L Canada Laboratories Inc., a research-driven technology company focused on sustainable development.

Khiron Raises $12.9 Million to Expand Colombia Medical Cannabis Operations

TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to announce that it has closed today its previously announced best efforts short form prospectus offering of common shares (“Common Shares”), including the exercise in

Continue Reading “Khiron Raises $12.9 Million to Expand Colombia Medical Cannabis Operations”

Canntab Therapeutics Launches Capital Markets Communications Strategy

Toronto, Ontario–(Newsfile Corp. – September 11, 2018) – Canntab Therapeutics Limited (CSE: PILL) (the “Company” or “Canntab”) is pleased to announce that, effective today, the Company will be increasing its level of engagement with shareholders and with potential retail and institutional investors. Accordingly, it has retained the services of Mackie Research Capital Corporation (“Mackie Research”)

Continue Reading “Canntab Therapeutics Launches Capital Markets Communications Strategy”

FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing

TORONTO, Sept. 11, 2018 /PRNewswire/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announces that pursuant to its Stock Option Plan, the Board approved the grant of 3,000,000 stock options for class B subordinate voting shares of the Company (the “Options”) on August 14, 2018 to Dr. Raza

Continue Reading “FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing”

Khiron Life Sciences A De Facto Beneficiary of Aurora Cannabis – ICC Labs Deal

FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation

TORONTO, Sept. 7, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today congratulated High Tide Ventures Inc. (“High Tide”) for the selection of its wholly-owned subsidiary Famous Brandz Inc. (“Famous Brandz”) as an accessories supplier to the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store

Continue Reading “FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation”

Enforcer Gold accelerates earn-in at Roger gold-copper project

TORONTO, Sept. 4, 2018 /CNW/ – Enforcer Gold Corp (“Enforcer” or the “Company”) (TSX-V: VEIN) (FSE: N071) is pleased to inform its shareholders that the Board of Directors has agreed to accelerate its earn-in schedule on the Roger gold-copper project, for which it recently announced an updated mineral resource estimate. The project is advantageously located 5

Continue Reading “Enforcer Gold accelerates earn-in at Roger gold-copper project”